The dilemma of 12/14F ureteral access sheath (UAS) usage: a case control study.


Journal

BMC urology
ISSN: 1471-2490
Titre abrégé: BMC Urol
Pays: England
ID NLM: 100968571

Informations de publication

Date de publication:
15 Jun 2022
Historique:
received: 19 09 2021
accepted: 25 04 2022
entrez: 15 6 2022
pubmed: 16 6 2022
medline: 18 6 2022
Statut: epublish

Résumé

The insertion of a ureteral access sheath (UAS) is a frequent procedure during flexible ureteroscopy (fURS) to facilitate kidney stone treatment. The aim of this study was to investigate the influence of 12/14 French (F) UAS on fURS outcomes. We performed a retrospective monocentric analysis of fURS procedures conducted at the Department of Urology (University Hospital Schleswig-Holstein, Lübeck, Germany) for kidney stone treatment via lithotripsy or basket stone retrieval between September 2013 and June 2017. Uni- and multivariate analyses were done with the help of RStudio (Version 1.0.136) software. In total, 283 consecutive fURS were analyzed. UAS was applied in 98 cases (34.63%). The insertion of UAS was preferred in cases with multiple kidney stones and larger median maximal stone diameter (p < 0.05). UAS usage correlated with elevated radiation exposure in seconds (94 vs. 61; p < 0.0001), prolonged operation time in minutes (99 vs. 66, p < 0.0001), length of hospital stay over 48 h (LOS, 22.49% vs. 10.81%; p = 0.015), more frequent postoperative systemic inflammatory response syndrome (SIRS, 13.27% vs. 4.32%; p = 0.013) and lower postoperative stone-free rates (60.20% vs. 78.92%; p = 0.0013). Moreover, we conducted uni- and multivariate subgroup analysis for cases with multiple kidney stones (≥ 2) and comparable stone burden; UAS was inserted in 48.3% of these cases (71/147). On multivariate logistic regression, UAS insertion was statistically associated with prolonged operation time in minutes (101 vs. 77; p = 0.004). No statistical differences regarding radiation exposure, stone-free rates, postoperative SIRS rates or LOS were noted between UAS and non-UAS patients with multiple kidney stones of similar size (p > 0.05). 12/14F UAS does not seem to improve overall outcomes in fURS for kidney stones. In patients with multiple kidney stones it may be associated with elevated operation time without a clear benefit in terms of improved stone-free status or reduced perioperative complication rate. Further prospective randomized studies to specify the indications for UAS usage are urgently needed.

Sections du résumé

BACKGROUND BACKGROUND
The insertion of a ureteral access sheath (UAS) is a frequent procedure during flexible ureteroscopy (fURS) to facilitate kidney stone treatment. The aim of this study was to investigate the influence of 12/14 French (F) UAS on fURS outcomes.
METHODS METHODS
We performed a retrospective monocentric analysis of fURS procedures conducted at the Department of Urology (University Hospital Schleswig-Holstein, Lübeck, Germany) for kidney stone treatment via lithotripsy or basket stone retrieval between September 2013 and June 2017. Uni- and multivariate analyses were done with the help of RStudio (Version 1.0.136) software.
RESULTS RESULTS
In total, 283 consecutive fURS were analyzed. UAS was applied in 98 cases (34.63%). The insertion of UAS was preferred in cases with multiple kidney stones and larger median maximal stone diameter (p < 0.05). UAS usage correlated with elevated radiation exposure in seconds (94 vs. 61; p < 0.0001), prolonged operation time in minutes (99 vs. 66, p < 0.0001), length of hospital stay over 48 h (LOS, 22.49% vs. 10.81%; p = 0.015), more frequent postoperative systemic inflammatory response syndrome (SIRS, 13.27% vs. 4.32%; p = 0.013) and lower postoperative stone-free rates (60.20% vs. 78.92%; p = 0.0013). Moreover, we conducted uni- and multivariate subgroup analysis for cases with multiple kidney stones (≥ 2) and comparable stone burden; UAS was inserted in 48.3% of these cases (71/147). On multivariate logistic regression, UAS insertion was statistically associated with prolonged operation time in minutes (101 vs. 77; p = 0.004). No statistical differences regarding radiation exposure, stone-free rates, postoperative SIRS rates or LOS were noted between UAS and non-UAS patients with multiple kidney stones of similar size (p > 0.05).
CONCLUSIONS CONCLUSIONS
12/14F UAS does not seem to improve overall outcomes in fURS for kidney stones. In patients with multiple kidney stones it may be associated with elevated operation time without a clear benefit in terms of improved stone-free status or reduced perioperative complication rate. Further prospective randomized studies to specify the indications for UAS usage are urgently needed.

Identifiants

pubmed: 35705924
doi: 10.1186/s12894-022-01031-6
pii: 10.1186/s12894-022-01031-6
pmc: PMC9199145
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

84

Informations de copyright

© 2022. The Author(s).

Références

J Endourol. 2008 Sep;22(9):2147-51
pubmed: 18811571
World J Urol. 2014 Feb;32(1):229-32
pubmed: 24166287
Urology. 2005 Aug;66(2):252-5
pubmed: 16040093
J Urol. 2001 Mar;165(3):789-93
pubmed: 11176469
Eur Urol. 2016 Mar;69(3):475-82
pubmed: 26344917
Urol Res. 2007 Apr;35(2):107-9
pubmed: 17393197
J Endourol. 2019 Sep;33(9):725-729
pubmed: 31266360
World J Urol. 2020 Aug;38(8):2035-2040
pubmed: 31659464
Urolithiasis. 2020 Jun;48(3):263-270
pubmed: 31372691
Cent European J Urol. 2015;68(4):434-8
pubmed: 26855796
J Urol. 2016 Oct;196(4):1153-60
pubmed: 27238616
Scand J Urol. 2016 Jun;50(3):216-9
pubmed: 27111193
BMC Urol. 2019 Jul 4;19(1):58
pubmed: 31272430
J Endourol. 2021 Apr;35(4):512-517
pubmed: 32967460
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Chest. 1992 Jun;101(6):1644-55
pubmed: 1303622
Urology. 2003 Apr;61(4):713-8
pubmed: 12670551
Urol Int. 2020;104(5-6):452-458
pubmed: 32097920
World J Urol. 2015 Dec;33(12):2137-44
pubmed: 25971204
J Endourol. 2014 Mar;28(3):286-90
pubmed: 24147776
PLoS One. 2018 Feb 28;13(2):e0193600
pubmed: 29489912
Urolithiasis. 2021 Dec;49(6):567-573
pubmed: 33847780
J Endourol. 2021 Sep;35(9):1340-1347
pubmed: 33827269
J Endourol. 2019 Sep;33(9):712-718
pubmed: 31161788

Auteurs

Tomasz Ozimek (T)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Judith R Wiessmeyer (JR)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Julian P Struck (JP)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Marie C Roesch (MC)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Nils Gilbert (N)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Jan M Laturnus (JM)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Axel S Merseburger (AS)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany.

Mario W Kramer (MW)

Department of Urology, University Hospital Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23562, Lübeck, Germany. mario.kramer@uksh.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH